Hotaling Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$2.55M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$1.67M |
| 3 |
Pfizer
PFE
|
+$1.54M |
| 4 |
Merck
MRK
|
+$1.45M |
| 5 |
Deere & Co
DE
|
+$906K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.11M |
| 2 |
Idexx Laboratories
IDXX
|
+$1.85M |
| 3 |
Ford
F
|
+$1.65M |
| 4 |
Teradyne
TER
|
+$1.35M |
| 5 |
Tapestry
TPR
|
+$1.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.5% |
| 2 | Healthcare | 20.21% |
| 3 | Financials | 12.59% |
| 4 | Consumer Discretionary | 9.79% |
| 5 | Industrials | 8.9% |
Similar funds
Hotaling Investment Management's Q2 2022 Portfolio in Review
As of Q2 2022, Hotaling Investment Management held 134 positions worth $230M, down 12% from $260M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Hotaling Investment Management deployed $8.69M of net new capital in Q2 2022, opening 7 new positions and adding to 89 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 6,222 shares worth $1.75M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $101K trimmed.
- Hotaling Investment Management's largest Q2 2022 buy was Vertex Pharmaceuticals: 6,222 shares worth $1.75M.
- Hotaling Investment Management added most to Johnson & Johnson in Q2 2022, an estimated $2.55M increase.
- Hotaling Investment Management's biggest Q2 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $101K.
- Hotaling Investment Management fully exited NVIDIA in Q2 2022, selling an estimated $3.11M.
- Hotaling Investment Management's ten largest holdings make up 37% of its $230M portfolio in Q2 2022.
- Hotaling Investment Management opened 7 new positions and closed 13 in Q2 2022.
- Hotaling Investment Management's portfolio value fell 12% quarter-over-quarter to $230M.
Based on Hotaling Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.